REPOST IHUB ADMINS THIS WAS NOT SPAM IT WAS A GOOD POST YOU GUYS
SPAM gimme a break RESTORE POST 165 OR TELL ME WHY IT IS SPAM
VRUS
Yeahhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh!!!!!!!! Gilead Sciences Inc. (GILD) agreed to acquire drug developer Pharmasset Inc. (VRUS) in a deal valued at about $10.4 billion that is expected to accelerate the development of treatments for hepatitis C.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.